Macrogenics (MGNX) Times Interest Earned (2023 - 2026)
Macrogenics (MGNX) reported Times Interest Earned of -$6.84 for Q1 2026, up 98.54% year-over-year from -$3.44 in Q1 2025, and down 141.54% quarter-over-quarter from -$2.83 in Q4 2025.
Macrogenics (MGNX) Times Interest Earned (2023 - 2026) Analysis & Trends
Macrogenics (MGNX) has 4 years of Times Interest Earned data on file, last reported at -$6.84 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$6.84, up 98.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.78 (up 99.65% YoY), and the FY2025 annual result was -$8.56, up 91.37% from the prior year.
- Times Interest Earned declined to -$6.84 in Q1 2026 per MGNX's latest filing, from -$2.83 in the prior quarter.
- Over five years, Times Interest Earned peaked at $2201.5 in Q4 2024 and troughed at -$9696.8 in Q2 2024.
- A 4-year average of -$817.77 and a median of -$46.64 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned slumped 16592.65% in 2024, then jumped 99.53% in 2025.
- A 4-year view of Times Interest Earned shows it stood at -$58.09 in 2023, then surged by 3889.85% to $2201.5 in 2024, then slumped by 100.13% to -$2.83 in 2025, then slumped by 141.54% to -$6.84 in 2026.
- Business Quant data shows MGNX's Times Interest Earned at -$6.84 in Q1 2026, -$2.83 in Q4 2025, and $5.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | -6.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.84 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | 5.58 |
| Jun 30, 2025 | -45.83 |
| Mar 31, 2025 | -468.40 |
| Dec 31, 2024 | 2,201.54 |
| Jun 30, 2024 | -9,696.83 |
| Mar 31, 2024 | -47.44 |
| Jun 30, 2023 | -58.09 |
| Mar 31, 2023 | -58.58 |